Deanna M Barch

Washington University in St. Louis, San Luis, Missouri, United States

Are you Deanna M Barch?

Claim your profile

Publications (304)1629.53 Total impact

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Major Depressive Disorder (MDD) is an extremely disabling disease that affects physiological, cognitive, and emotional functioning. The literature has been conflicted regarding the relationship between MDD and emotional responsivity, particularly to negative stimuli. However, in prior work, we showed that individual differences in MDD's gateway symptoms, anhedonia (loss of pleasure) and depressed mood, predicted differential effects on emotional response to affective stimuli in a non-clinical sample. Furthermore, we found that current mood predicted emotional responsivity above and beyond anhedonia and depressed mood. The current study aims to induce moods in a large non-clinical sample to examine whether induced mood can affect emotion responsivity. The following is data from a pilot study used to determine the efficacy of different film clips for inducing negative, positive, and neutral mood.
    Washington University in St. Louis Undergraduate Research Symposium, Washington University in St. Louis; 10/2014
  • Abhishek Saxena, David Pagliaccio, Katherine R. Luking, Deanna M. Barch
    [Show abstract] [Hide abstract]
    ABSTRACT: Major Depressive Disorder (MDD) is an extremely disabling disease that affects physiological, cognitive, and emotional functioning. The literature has been conflicted regarding the relationship between MDD and emotional responsivity, particularly to negative stimuli. However, in prior work, we showed that individual differences in MDD's gateway symptoms, anhedonia (loss of pleasure) and depressed mood, predicted differential effects on emotional response to affective stimuli in a non-clinical sample. Furthermore, we found that current mood predicted emotional responsivity above and beyond anhedonia and depressed mood. The current study aims to induce moods in a large non-clinical sample to examine whether induced mood can affect emotion responsivity. The following is data from a pilot study used to determine the efficacy of different film clips for inducing negative, positive, and neutral mood.
    Washington University in St. Louis Undergraduate Research Symposium, Washington University in St. Louis; 10/2014
  • Abhishek Saxena, David Pagliaccio, Katherine R Luking, Deanna M Barch
    [Show abstract] [Hide abstract]
    ABSTRACT: Major Depressive Disorder (MDD) is an extremely disabling disease that affects physiological, cognitive, and emotional functioning. The literature has been conflicted regarding the relationship between MDD and emotional responsivity, particularly to negative stimuli. However, in prior work, we showed that individual differences in MDD's gateway symptoms, anhedonia (loss of pleasure) and depressed mood, predicted differential effects on emotional response to affective stimuli in a non-clinical sample. Furthermore, we found that current mood predicted emotional responsivity above and beyond anhedonia and depressed mood. The current study aims to induce moods in a large non-clinical sample to examine whether induced mood can affect emotion responsivity. The following is data from a pilot study used to determine the efficacy of different film clips for inducing negative, positive, and neutral mood.
    Washington University in St. Louis Undergraduate Research Symposium, Washington University in St. Louis; 10/2014
  • Deanna M. Barch, Julia M. Sheffield
    [Show abstract] [Hide abstract]
    ABSTRACT: Decades of research have provided robust evidence of cognitive impairments in psychotic disorders. Individuals with schizophrenia appear to be impaired on the majority of neuropsychological tasks, leading some researchers to argue for a “generalized deficit”, in which the multitude of cognitive impairments are the result of a common neurobiological source. One such common mechanism may be an inability to actively represent goal information in working memory as a means to guide behavior, with the associated neurobiological impairment being a disturbance in the function of the dorsolateral prefrontal cortex. Here, we provide a discussion of the evidence for such impairment in schizophrenia, and how it manifests in domains typically referred to as cognitive control, working memory and episodic memory. We also briefly discuss cognitive impairment in affective psychoses, reporting that the degree of impairment is worse in schizophrenia than in bipolar disorder and psychotic major depression, but the profile of impairment is similar, possibly reflecting common mechanisms at the neural level. Given the recent release of the DSM-5, we end with a brief discussion on assessing cognition in the context of diagnosis and treatment planning in psychotic disorders.
    World Psychiatry. 10/2014; 13(3).
  • Source
    Society for Research in Psychopathology, Evanston, IL; 09/2014
  • Source
    Flux Congress, Los Angeles, CA; 09/2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: To determine if late preterm (LP) children differ from full term (FT) children in volumes of the cortex, hippocampus, corpus callosum, or amygdala and whether these differences are associated with anxiety symptoms at school-age.
    The Journal of pediatrics. 08/2014;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Pharmacological enhancement of prefrontal D1 dopamine receptor function remains a promising therapeutic approach to ameliorate schizophrenia-spectrum working memory deficits, but has yet to be rigorously evaluated clinically. This proof-of-principle study sought to determine whether the active enantiomer of the selective and full D1 receptor agonist dihydrexidine (DAR-0100A) could attenuate working memory impairments in unmedicated patients with schizotypal personality disorder (SPD). We performed a randomized, double-blind, placebo-controlled trial of DAR-0100A (15 mg/150 ml of normal saline administered intravenously over 30 min) in medication-free patients with SPD (n=16) who met criteria for cognitive impairment (i.e., scoring below the 25(th) percentile on tests of working memory). We employed two measures of verbal working memory that are salient to schizophrenia-spectrum cognitive deficits, and clinical data implicate as being associated with prefrontal D1 availability: 1) the Paced Auditory Serial Addition Test (PASAT); and 2) the N-back test (ratio of 2-back:0-back scores). Study procedures occurred over four consecutive days with working memory testing on Days 1 and 4, and DAR-0100A/placebo administration on Days 2-4. Treatment with DAR-0100A was associated with significantly improved PASAT performance relative to placebo, with a very large effect size (Cohen's d=1.14 for both tests). Performance on the N-back ratio was also significantly improved, however, this effect rested on both a non-significant enhancement and diminution of 2-back and 0-back performance, respectively; therefore interpretation of this finding is more complicated. DAR-0100A was generally well tolerated, with no serious medical or psychiatric adverse events; common side-effects were mild-to-moderate and transient, consisting mainly of sedation, lightheadedness, tachycardia, and hypotension; however, we were able to minimize these effects, without altering the dose, with supportive measures, e.g., co-administered normal saline. Although preliminary, these findings lend further clinical support to the potential of D1 receptor agonists to treat schizophrenia-spectrum working memory impairments. These data suggest a need for further studies with larger group sizes, serum DAR-0100A levels, and a more comprehensive neuropsychological battery.Neuropsychopharmacology accepted article preview online, 30 July 2014; doi:10.1038/npp.2014.192.
    Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 07/2014; · 8.68 Impact Factor
  • Source
    Katherine R. Luking, Joan Luby, Deanna M. Barch
    [Show abstract] [Hide abstract]
    ABSTRACT: The development of reward-related neural systems, from adolescence through adulthood, has received much recent attention in the developmental neuroimaging literature. However, few studies have investigated behavioral and neural responses to both gains and losses in pre-pubertal child populations. To address this gap in the literature, in the present study healthy children aged 7-11 years and young-adults completed an fMRI card-guessing game using candy pieces delivered post-scan as an incentive. Age differences in behavioral and neural responses to candy gains/losses were investigated. Adults and children displayed similar responses to gains, but robust age differences were observed following candy losses within the caudate, thalamus, insula, and hippocampus. Interestingly, when task behavior was included as a factor in post-hoc mediation analyses, activation following loss within the caudate/thalamus related to task behavior and relationships with age were no longer significant. Conversely, relationships between response to loss and age within the hippocampus and insula remained significant even when controlling for behavior, with children showing heightened loss responses within the dorsal/posterior insula. These results suggest that both age and task behavior influence responses within the extended reward circuitry, and that children seem to be more sensitive than adults to loss feedback particularly within the dorsal/posterior insula.
    Developmental Cognitive Neuroscience. 07/2014;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective Previous studies have examined the relationships between structural brain characteristics and early life stress in adults. However, there is limited evidence for functional brain variation associated with early life stress in children. We hypothesized that early life stress and trauma would be associated with increased functional brain activation to negative emotional faces in children with and without a history of depression. Method Psychiatric diagnosis and life events in children (starting at ages 3-5) were assessed in a longitudinal study. A follow-up magnetic resonance imaging (MRI) study acquired data (N = 115 at ages 7-12, 51% female) on functional brain response to fearful, sad, and happy faces relative to neutral faces. We used a region of interest (ROI) mask within cortico-limbic areas and conducted regression analyses and repeated-measures analysis of covariance (ANCOVA). Results Greater activations to fearful, sad, and happy faces in the amygdala and its neighboring regions were found in children with higher life stress. Moreover, an association between life stress and left hippocampal and globus pallidus activity depended on children’s diagnostic status. Finally, all children with higher life trauma showed greater bilateral amygdala and cingulate activity specific to sad faces, but not the other emotional faces, although right amygdala activity was moderated by psychiatric status. Conclusions These findings may suggest that limbic hyperactivity is a biomarker of early life stress and trauma in children and may have implications in the risk trajectory for depression and other stress-related disorders. However, this pattern varied based on emotion type and history of psychopathology.
    Journal of the American Academy of Child and Adolescent Psychiatry 07/2014; 53(7):800-813.e10. · 6.97 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent years have seen a rejuvenation of interest in studies of motivation-cognition interactions arising from many different areas of psychology and neuroscience. The present issue of Cognitive, Affective, & Behavioral Neuroscience provides a sampling of some of the latest research from a number of these different areas. In this introductory article, we provide an overview of the current state of the field, in terms of key research developments and candidate neural mechanisms receiving focused investigation as potential sources of motivation-cognition interaction. However, our primary goal is conceptual: to highlight the distinct perspectives taken by different research areas, in terms of how motivation is defined, the relevant dimensions and dissociations that are emphasized, and the theoretical questions being targeted. Together, these distinctions present both challenges and opportunities for efforts aiming toward a more unified and cross-disciplinary approach. We identify a set of pressing research questions calling for this sort of cross-disciplinary approach, with the explicit goal of encouraging integrative and collaborative investigations directed toward them.
    Cognitive Affective & Behavioral Neuroscience 06/2014; · 3.87 Impact Factor
  • Deanna M Barch
    Schizophrenia bulletin. 06/2014;
  • Deanna M Barch
    Journal of the American Academy of Child and Adolescent Psychiatry 05/2014; 53(5):497-9. · 6.97 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Major Depressive Disorder (MDD) is an extremely debilitating disorder with respect to physical, psychological, and emotional functioning. However, impairment in people with MDD may vary drastically based on the cluster of symptoms that people exhibit and the severity of those symptoms. The present study examines the relationship between the two gateway symptoms for diagnosis of MDD, anhedonia and depressed mood, and emotional reactivity within a large non-clinical sample. To this end, participants (N=107) were asked to complete an Emotional Picture Rating Task (EPRT). The EPRT required participants to rate the valence and arousal level of their emotional response to 100 pictures (40 negative, 20 neutral, and 40 positive pictures) from the International Affective Picture System. In addition, participants completed self-report questionnaires used to assess levels of hedonic capacity, general affect, and depressive symptomology. We found that elevated levels of anhedonia (i.e. decreased hedonic capacity) predicted blunted emotional reactivity to both positive and negative pictures, while elevated depressive symptoms predicted potentiated negative emotional reactivity to negative pictures. These findings are consistent with current literature that suggests that MDD affects emotional processing, but suggests that different symptoms affect emotional processing in different ways. These findings could suggest that treatment of MDD should be approached at a symptomatic level rather than at a generalized level.
    Washington University in St. Louis Undergraduate Research Symposium, Washington University in St. Louis; 04/2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The relationship between Major Depressive Disorder (MDD) and reduced reward response is well documented in adult and adolescent MDD literatures [1-2]. Conversely, adults and adolescents with MDD show enhanced responses to loss/negative stimuli [1,3]. However, as reward-related behaviors and adaptive responses to negative feedback undergo dramatic changes across puberty [4-5], key questions remain regarding how altered gain and loss processing relates to depressive and anhedonic symptoms in pre-pubertal child populations. Twenty-four pre-pubertal children aged 7-10 years completed two signal detection tasks that assessed behavioral responsivity to candy gain and loss feedback, respectively. These tasks were based on Pizzagalli's probabilistic reward task where asymmetric feedback leads to greater response bias in more hedonic/non-depressed adults. We further modified the task to create a version where incorrect responses could result in loss feedback [6,7]. Children and parents also completed individual difference questionnaires to assess child depressive symptomology, general affect, and approach motivation/hedonic capacity. Hierarchical regressions indicated a relationship between approach motivation/hedonic capacity and response bias in both gain and loss tasks, even when controlling for depressive and externalizing symptoms. No relationships between depressive symptoms and bias were observed. Results suggest that reduced approach motivation/hedonic capacity is associated with blunted responses to both gain and loss feedback in pre-pubertal children, independent of other depressive symptoms.
    The Society for Affective Science; 04/2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: When used effectively, cognitive reappraisal of distressing events is a highly adaptive cognitive emotion regulation (CER) strategy, with impairments in cognitive reappraisal associated with greater risk for psychopathology. Despite extensive literature examining the neural correlates of cognitive reappraisal in healthy and psychiatrically ill adults, there is a dearth of data to inform the neural bases of CER in children, a key gap in the literature necessary to map the developmental trajectory of cognitive reappraisal. In this fMRI study, psychiatrically healthy schoolchildren were instructed to use cognitive reappraisal to modulate their emotional reactions and responses of negative affect after viewing sad photos. Consistent with the adult literature, when actively engaged in reappraisal compared to passively viewing sad photos, children showed increased activation in the vlPFC, dlPFC, and dmPFC as well as in parietal and temporal lobe regions. When children used cognitive reappraisal to minimize their experience of negative affect after viewing sad stimuli they exhibited dampened amygdala responses. Results are discussed in relation to the importance of identifying and characterizing neural processes underlying adaptive CER strategies in typically developing children in order to understand how these systems go awry and relate to the risk and occurrence of affective disorders.
    Developmental cognitive neuroscience. 02/2014; 9C:136-147.
  • Source
    Dataset: mmc1
    Katherine R. Luking, Joan Luby, Deanna M. Barch
  • Jared X Van Snellenberg, Deanna M Barch
    Cognitive Affective & Behavioral Neuroscience 01/2014; · 3.87 Impact Factor
  • Ann M Kring, Deanna M Barch
    [Show abstract] [Hide abstract]
    ABSTRACT: A range of emotional and motivation impairments have long been clinically documented in people with schizophrenia, and there has been a resurgence of interest in understanding the psychological and neural mechanisms of the so-called "negative symptoms" in schizophrenia, given their lack of treatment responsiveness and their role in constraining function and life satisfaction in this illness. Negative symptoms comprise two domains, with the first covering diminished motivation and pleasure across a range of life domains and the second covering diminished verbal and non-verbal expression and communicative output. In this review, we focus on four aspects of the motivation/pleasure domain, providing a brief review of the behavioral and neural underpinnings of this domain. First, we cover liking or in-the-moment pleasure: immediate responses to pleasurable stimuli. Second, we cover anticipatory pleasure or wanting, which involves prediction of a forthcoming enjoyable outcome (reward) and feeling pleasure in anticipation of that outcome. Third, we address motivation, which comprises effort computation, which involves figuring out how much effort is needed to achieve a desired outcome, planning, and behavioral response. Finally, we cover the maintenance emotional states and behavioral responses. Throughout, we consider the behavioral manifestations and brain representations of these four aspects of motivation/pleasure deficits in schizophrenia. We conclude with directions for future research as well as implications for treatment.
    European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology 01/2014; · 3.68 Impact Factor
  • Source

Publication Stats

16k Citations
1,629.53 Total Impact Points

Institutions

  • 1999–2014
    • Washington University in St. Louis
      • • Department of Psychiatry
      • • Department of Psychology
      San Luis, Missouri, United States
  • 2013
    • Vanderbilt University
      Nashville, Michigan, United States
    • University of Oxford
      • Oxford Centre for Functional MRI of the Brain (FMRIB Centre)
      Oxford, England, United Kingdom
    • University of Florida
      Gainesville, Florida, United States
    • The Psychonomic Society
      Society Hill, New Jersey, United States
    • CUNY Graduate Center
      New York City, New York, United States
    • CSU Mentor
      Long Beach, California, United States
    • New York State Psychiatric Institute
      New York City, New York, United States
  • 2008–2013
    • Washington & Lee University
      Lexington, Virginia, United States
    • University of Missouri
      • Department of Psychological Sciences
      Columbia, MO, United States
    • Princeton University
      Princeton, New Jersey, United States
  • 2012
    • Rutgers New Jersey Medical School
      Newark, New Jersey, United States
    • Skidmore College
      • Department of Psychology
      Saratoga Springs, NY, United States
    • Community Health Center, Connecticut
      Middletown, Connecticut, United States
    • National Institute of Mental Health (NIMH)
      • Laboratory of Brain And Cognition
      Maryland, United States
  • 2010–2012
    • University of Ljubljana
      • Department of Psychology
      Ljubljana, Ljubljana, Slovenia
    • Harvard University
      Cambridge, Massachusetts, United States
  • 2005–2012
    • University of Washington Seattle
      • • Department of Psychology
      • • Department of Neurology
      • • Department of Radiology
      Seattle, WA, United States
    • University of Minnesota Twin Cities
      • Department of Psychology
      Minneapolis, MN, United States
  • 2011
    • National Institute on Alcohol Abuse and Alcoholism
      Maryland, United States
    • University of Maryland, Baltimore
      • Department of Psychiatry
      Baltimore, MD, United States
    • Rhode Island Hospital
      Providence, Rhode Island, United States
    • Yale University
      • Department of Psychiatry
      New Haven, CT, United States
  • 2008–2011
    • Northwestern University
      • • Feinberg School of Medicine
      • • Department of Psychiatry and Behavioral Sciences
      Evanston, IL, United States
  • 2004–2011
    • Washington School of Psychiatry
      Washington, Washington, D.C., United States
    • University of Missouri - St. Louis
      Saint Louis, Michigan, United States
  • 2007–2010
    • University of California, Davis
      • Center for Comparative Medicine
      Davis, CA, United States
  • 2007–2008
    • Mount Sinai School of Medicine
      • Department of Psychiatry
      Manhattan, NY, United States
  • 2004–2008
    • University of California, Los Angeles
      • Department of Psychology
      Los Angeles, CA, United States
  • 2006
    • Mayo Foundation for Medical Education and Research
      Rochester, Michigan, United States
  • 1996–2005
    • University of Pittsburgh
      • Department of Psychiatry
      Pittsburgh, PA, United States
  • 2003
    • Howard Hughes Medical Institute
      Ashburn, Virginia, United States
  • 2001
    • Carnegie Mellon University
      • Department of Psychology
      Pittsburgh, PA, United States
  • 1994–1997
    • University of Illinois, Urbana-Champaign
      • Department of Psychology
      Urbana, IL, United States